A new treatment for asthma attack ... the first in 50 years

In a scientific and medical achievement scientists from Kings College London College announced the development of a new treatment for asthma attacks and chronic lung bell bucketing in 50 years. The new treatment is an injection given in emergency situations during symptoms, and its effectiveness has been proven compared to traditional treatment using steroid tablets. The study, published in the magazine “The Lancet Respiryo medicine. An asthma attacks are an asthma attack and the exacerbation of the symptoms of chronic pulmonary obstruction is one of the most dangerous respiratory symptoms that can threaten life as it is a major burden on health services all over the world, and the basic treatment for the ASJA Pulmbly treatment, depends on the ASJA attacks and the extract of the excerpt of the pulse treatment, depends on ASJA attacks and is the extract of the extract, and it is dependent on the ASJA attacks and is the extract of the pulse treatment, and it depends on the extract of the extract, -All and is the extract of the extract, and it depends on ASJA attacks and depends on the exposition of the extract of the extract of the front. asthma. The drug is aimed at a kind of white immune cell known as Esenovilat, which plays a major role in causing inflammation associated with asthma and chronic obstructive obstruction, and in these cases, a large number of Ezinovilat collects in the airway, which exacerbates symptoms, such as coughing, whistling and whistling. Benralzumab is directly aimed at these cells, which is a single-style antibiotic associated with the IL-5 (IL-5) receptors on the surface of the Ezinovilat. The single -style medicine is a kind of antibodies produced in the laboratory using completely similar cells, and these antibodies come from one cell called a nassila cell, which is a cell that produces one type of antibodies, and since all these cells are identical, the antibodies are also identical. In the case of Benralzumab, the drug is targeted by Intercin-5 (IL-5) receptors on the surface of the Ezinovilat, thus directing the immune system to destroy these immune cells that contribute to asthma infections and chronic pulmonary obstruction by directly destroying Ezenovilat; Leading to an effective reduction in inflammation. The study relied on a double blind design, as the participants were divided into three groups: a group that received an injection from Naramab with false tablets, and another who received traditional treatment (prednisolone) with false injection, and a third who received both treatment. After 28 days, the results showed a noticeable improvement in the symptoms of coughing, whistling and shortness of breath in the group that received the Naralalalalalap compared to traditional treatment, and the treatment figures dropped to 90 days to a quarter of cases in the group who received the injection compared to those who only took steroid. The experience of the second phase of the clinical study conducted in collaboration between the University of Oxford and “Kings College London” showed that one injection of Benralzumab during Nubia was more effective than traditional steroid tablets. A safe and effective treatment, and the researchers described the new treatment as a ‘radical change’ in the way to deal with asthma attacks and the exacerbation of pulmonary blockage, as the treatment of these seizures did not change 50 years ago, although it caused the death of 3.8 million people all over the world annually. The researchers believe that Benralzumab is a safe and effective drug, and the study has shown that it can be more effective when used during attacks compared to traditional steroid tablets. This treatment is expected to be available for use in hospitals, doctor’s clinics or even at home, making it easier for patients, and this performance also offers new hope for more than a billion people around the world suffering from asthma or pulmonary obstruction. “When I had an attack, it was impossible to describe my feeling, I could barely breathe, and after using the injection I felt a great improvement and I no longer had the annoying side effects of the steroid,” said one of the patients who participated in the study.